Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer: the phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 June 2016
|
| In: |
European journal of cancer
Year: 2016, Volume: 64, Pages: 12-21 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2016.05.015 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2016.05.015 Verlag, Volltext: http://www.ejcancer.com/article/S0959-8049(16)32146-3/fulltext |
| Author Notes: | G. von Minckwitz, M. Rezai, H. Tesch, J. Huober, B. Gerber, D.M. Zahm, J. Hilfrich, S.D. Costa, P. Dubsky, J.U. Blohmer, C. Denkert, C. Hanusch, C. Jackisch, S. Kümmel, P.A. Fasching, A. Schneeweiss, S. Paepke, M. Untch, N. Burchardi, K. Mehta, S. Loibl for the German Breast Group and Austrian Breast and ColonCancer Study Group Investigators |
| Item Description: | Gesehen am 21.02.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2016.05.015 |